Please use this identifier to cite or link to this item:
|Title:||Smart Pharmaceutical Manufacturing: Ensuring End-to-End Traceability and Data Integrity in Medicine Production|
Chis, Adriana E.
García–Gómez, Juan M.
|Citation:||Leal, F., Chis, A. E., Caton, S., González–Vélez, H., García–Gómez, J. M., et al. (2021). Smart Pharmaceutical Manufacturing: Ensuring End-to-End Traceability and Data Integrity in Medicine Production. Big Data Research, 24, 1-12. DOI: https://doi.org/10.1016/j.bdr.2020.100172. Disponível no Repositório UPT, http://hdl.handle.net/11328/3347|
|Abstract:||Production lines in pharmaceutical manufacturing generate numerous heterogeneous data sets from various embedded systems which control the multiple processes of medicine production. Such data sets should arguably ensure end-to-end traceability and data integrity in order to release a medicine batch, which is uniquely identified and tracked by its batch number/code. Consequently, auditable computerised systems are crucial on pharmaceutical production lines, since the industry is becoming increasingly regulated for product quality and patient health purposes. This paper describes the EU- funded SPuMoNI project, which aims to ensure the quality of large amounts of data produced by computerised production systems in representative pharmaceutical environments. Our initial results include significant progress in: (i) end-to-end verification taking advantage of blockchain properties and smart contracts to ensure data authenticity, transparency, and immutability; (ii) data quality assessment models to identify data behavioural patterns that can violate industry practices and/or international regulations; and (iii) intelligent agents to collect and manipulate data as well as perform smart decisions. By analysing multiple sensors in medicine production lines, manufacturing work centres, and quality control laboratories, our approach has been initially evaluated using representative industry- grade pharmaceutical manufacturing data sets generated at an IT environment with regulated processes inspected by regulatory and government agencies.|
|Appears in Collections:||REMIT – Artigos em Revistas Internacionais / Papers in International Journals|
Files in This Item:
|Smart Pharmaceutical Manufacturing.pdf||2.23 MB||Adobe PDF||View/Open|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.